comparemela.com
  1. Home
  2. Live Updates
  3. Ascletis Announces Poster Presentation of Phase II Study Topline Results of FASN Inhibitor ASC40 for Treatment of Acne at EADV Congress 2023 : comparemela.com

Ascletis Announces Poster Presentation of Phase II Study Topline Results of FASN Inhibitor ASC40 for Treatment of Acne at EADV Congress 2023

Ascletis Announces Poster Presentation of Phase II Study Topline Results of FASN Inhibitor ASC40 for Treatment of Acne at EADV Congress 2023

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China ,Hangzhou ,Zhejiang ,Hong Kong ,Huashan ,Henan ,Germany ,Berlin ,Shaoxing ,Jinzij Wu ,Leihong Xiang ,Sagimet Biosciences Inc ,Ascletis Pharma Inc ,Fudan University ,European Academy Of Dermatology ,Hong Kong Stock Exchange ,Ascletis Pharma ,European Academy ,Professor Leihong Xiang ,Huashan Hospital ,Global Assessment ,Sagimet Biosciences ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.